| Literature DB >> 33103565 |
Laura Wicke1,2, Falk Ponath3, Lucas Coppens2, Milan Gerovac1, Rob Lavigne2, Jörg Vogel1,3.
Abstract
As part of the ongoing renaissance of phage biology, more phage genomes are becoming available through DNA sequencing. However, our understanding of the transcriptome architecture that allows these genomes to be expressed during host infection is generally poor. Transcription start sites (TSSs) and operons have been mapped for very few phages, and an annotated global RNA map of a phage - alone or together with its infected host - is not available at all. Here, we applied differential RNA-seq (dRNA-seq) to study the early, host takeover phase of infection by assessing the transcriptome structure of Pseudomonas aeruginosa jumbo phage ɸKZ, a model phage for viral genetics and structural research. This map substantially expands the number of early expressed viral genes, defining TSSs that are active ten minutes after ɸKZ infection. Simultaneously, we record gene expression changes in the host transcriptome during this critical metabolism conversion. In addition to previously reported upregulation of genes associated with amino acid metabolism, we observe strong activation of genes with functions in biofilm formation (cdrAB) and iron storage (bfrB), as well as an activation of the antitoxin ParD. Conversely, ɸKZ infection rapidly down-regulates complexes IV and V of oxidative phosphorylation (atpCDGHF and cyoABCDE). Taken together, our data provide new insights into the transcriptional organization and infection process of the giant bacteriophage ɸKZ and adds a framework for the genome-wide transcriptomic analysis of phage-host interactions.Entities:
Keywords: Bacteriophage ɸKZ; Pseudomonas aeruginosa; dRNA-seq; differential expression; phage-host interaction; transcription start site
Mesh:
Substances:
Year: 2020 PMID: 33103565 PMCID: PMC8244752 DOI: 10.1080/15476286.2020.1827785
Source DB: PubMed Journal: RNA Biol ISSN: 1547-6286 Impact factor: 4.652
Figure 1.Experimental workflow of dRNA-seq and TSS annotation in PAO1. (A) Total RNA of P. aeruginosa PAO1 was extracted, during or without ɸKZ infection. To distinguish between processed and primary transcripts, one library was treated with terminator exonuclease (+TEX) whereas the other was not (-TEX). After sequencing and genome-analysis by ANNOgesic, specific enrichment patterns were visualized and annotated according to those TSSs. (B) TSS categories and their overlaps are displayed in a Venn diagram. The majority of detected TSSs are associated with multiple categories. However, 1,821 out of 3,108 were annotated as primary TSSs. (C) Schematic representation of TSS categorization in primary (P), secondary (S), internal (I), antisense (as) and orphan (O). (D) Partition of 5´UTR lengths of 2,187 TSSs (primary and secondary) of PAO1 transcripts by their size. Transcripts with a 5´UTR lengths < 10 nt were defined as leaderless transcripts. Most transcripts possess a 5´UTR length between 21–30 nt whereas no transcripts were detected with 5´UTR lengths >300 nt
Summary of the number of uniquely aligned reads (excluding rRNA reads) mapped to the P. aeruginosa PAO1 (DSM22644) reference sequence and the ɸKZ sequence. For all libraries, PAO1 cells were grown to an OD of 0.3 in LB media. Samples infected in this growth state and cultures were harvested after 10 min of infection
| Number of uniquely aligned reads | |||
|---|---|---|---|
| Sample | Treatment | PAO1 | ɸKZ |
| 1.1 | -TEX | 2,673,749 | 49 |
| 1.2 | -TEX | 2,117,710 | 48 |
| 2.1 | -TEX | 1,659,429 | 887,671 |
| 2.2 | -TEX | 1,159,527 | 861,150 |
Figure 2.TSS annotation of ɸKZ and motif searches. (A) Two examples of 5´-end enrichment patterns observed by TEX treatment of ɸKZ transcripts. For PHIKZ260, a primary TSS was detected whereas a primary and secondary TSS could be distinguished for PHIKZ054. The distance between the TSS and the AUG start codon is indicated. (B) Venn diagram provides a detailed view on detected viral TSSs and shows their overlaps. The majority of all 65 viral TSSs is categorized as primary, whereas just a few can be associated to the other four categories. (C) 5´UTR lengths of ɸKZ mRNAs are depicted. The majority possess a length between 31 and 40 nt, which is longer than the median length of host transcripts. Interestingly, no leaderless transcript could be detected. (D) Giant bacteriophage ɸKZ early promoter sequence found for 32 sequences. Motif searches were conducted by MEME analysis, using 50 nt sequences upstream of all primary TSSs. (E) For 28 TSSs, one more promoter motif was found using MEME analysis and characterized by a TACT motif followed by an A-repeat
List of downregulated PAO1 transcripts during phage infection
| locus tag | gene name | product description | average ctrl | average infection | log2fold change | p-value | |
|---|---|---|---|---|---|---|---|
| cell wall | PA3146 | probable NAD-dependent epimerase/dehydratase | 669.5 | 102 | −2.36 | 5.69E-33 | |
| PA3148 | UDP-N-acetylglucosamine-2-epidermase | 1272.5 | 185.5 | −2.41 | 5.05E-53 | ||
| PA3149 | probable glycosyltransferase | 1303.5 | 158.5 | −2.67 | 9.85E-60 | ||
| PA3150 | LPS biosynthesis protein | 1259 | 150.5 | −2.69 | 5.50E-58 | ||
| PA3151 | imidazoleglycerol-phosphate synthase, cyclase subunit | 1053 | 124 | −2.71 | 1.15E-55 | ||
| PA3152 | glutamine amidotransferase | 722.5 | 85.5 | −2.70 | 2.07E-46 | ||
| PA3153 | O-antigen translocase | 835 | 75.75 | −3.08 | 4.08E-59 | ||
| PA3154 | B-band O-antigen polymerase | 1048.5 | 106.5 | −2.93 | 2.29E-61 | ||
| PA3155 | UDP-2-acetamido-2-dideoxy-d-ribo-hex-3-uluronic acid transaminase | 1313.5 | 195 | −2.38 | 4.08E-49 | ||
| PA3157 | probable acetyltransferase | 1467 | 250.5 | −2.18 | 4.38E-47 | ||
| energy | PA5553 | ATP synthase epsilon chain | 1582 | 304.5 | −2.00 | 2.93E-42 | |
| PA5554 | ATP synthase beta chain | 14256 | 2730.1 | −2.03 | 7.11E-37 | ||
| PA5555 | ATP synthase gamma chain | 11046 | 1860 | −2.21 | 2.42E-36 | ||
| PA5557 | ATP synthase delta chain | 8259 | 1444.5 | −2.15 | 3.22E-38 | ||
| PA5558 | ATP synthase B chain | 7642 | 1440 | −2.03 | 2.33E-48 | ||
| electron transport | PA1317 | cytochrome bo3 ubiquinole oxidase subunit II | 696.2 | 85 | −2.67 | 1.27E-31 | |
| PA1318 | cytochrome bo3 ubiquinole oxidase subunit I | 1236.6 | 167.5 | −2.54 | 7.05E-34 | ||
| PA1319 | cytochrome bo3 ubiquinole oxidase subunit III | 424 | 55.5 | −2.58 | 7.37E-24 | ||
| PA1320 | cytochrome bo3 ubiquinole oxidase subunit IV | 244 | 32 | −2.57 | 6.41E-19 | ||
| PA1321 | cytochrome o ubiquinole oxidase protein | 123 | 19 | −2.32 | 4.69E-11 | ||
| secretion systems | PA1694 | translocation protein in type III secretion | 58 | 9.5 | −2.26 | 4.06E-05 | |
| PA1697 | ATP synthase in type III secretion system | 135 | 24.5 | −2.08 | 3.09E-12 | ||
| PA1703 | type III secretory apparatus protein PcrD | 197.5 | 32.5 | −2.21 | 1.22E-13 | ||
| PA1706 | type III secretion protein | 151.5 | 27 | −2.13 | 6.04E-11 | ||
| PA1707 | regulatory protein | 73.5 | 8.5 | −2.76 | 1.87E-07 | ||
| PA1716 | type III secretion outer membrane proteinPscC precursor | 218.5 | 32.7 | −2.35 | 5.81E-17 | ||
| PA1717 | type III export protein PscD | 136 | 25.5 | −2.08 | 8.72E-10 | ||
| PA1718 | type III export protein | 75 | 10.5 | −2.49 | 1.72E-07 | ||
| PA1719 | type III export protein | 138.5 | 18 | −2.61 | 1.02E-11 | ||
| PA1722 | type III export protein PscI | 116 | 22 | −2.03 | 1.04E-08 | ||
| unknown cluster | PA2730 | Hypothetical protein | 459.5 | 60 | −2.57 | 2.24E-29 | |
| PA2731 | Uncharacterized protein | 286.5 | 44 | −2.33 | 2.58E-21 | ||
| PA2732 | Hypothetical protein | 1508 | 278.5 | −2.07 | 1.42E-38 | ||
| PA2733 | Conserved hypothetical protein | 419 | 52.5 | −2.63 | 1.68E-26 | ||
| regulators of virulence | PA1431 | regulatory protein | 414 | 57.5 | −2.46 | 1.38E-27 | |
| PA1003 | transcriptional regulator | 176 | 29 | −2.23 | 1.05E-13 | ||
| PA1713 | transcriptional regulator | 728 | 79 | −2.84 | 3.43E-42 | ||
| PA2591 | VqsR | 96 | 17.7 | −2.1 | 1.16E-09 | ||
| PA2390 | PvdT | 73.5 | 12 | −2.22 | 5.10E-07 |
List of upregulated PAO1 transcripts during phage infection
| locus tag | gene name | product description | average ctrl | average infection | log2fold change | p-value | |
|---|---|---|---|---|---|---|---|
| biofilm | PA4624 | cyclic diguanylate-regulated TPS partner B | 27.5 | 104.5 | 2.35 | 1.77E-11 | |
| PA4625 | cyclic diguanylate-regulated TPS partner A | 66 | 844.5 | 4.11 | 1.67E-81 | ||
| arginine | PA5171 | argenine deiminase | 33 | 111.3 | 2.38 | 5.24E-02 | |
| PA5172 | ornithine carbamoyltransferase, catabolic | 37 | 142.3 | 2.52 | 3.37E-02 | ||
| PA5173 | carbamate kinase | 15.5 | 70.6 | 2.85 | 1.64E-02 | ||
| leucine | PA2015 | putative isovaleryl-CoA dehydrogenase | 39 | 147.5 | 2.32 | 1.22E-16 | |
| PA2016 | regulator of liu genes | 31 | 163.5 | 2.80 | 7.57E-20 | ||
| phenylalanine | PA0865 | 4-hydroxyphenylpyruvate dioxygenase | 55.1 | 176.6 | 2.09 | 1.15E-18 | |
| unknown cluster | PA0492 | conserved hypothetical protein | 19 | 122.4 | 3.10 | 7.32E-21 | |
| PA0494 | probable acyl-CoA carboxylase | 11 | 51 | 2.64 | 5.42E-08 | ||
| PA0495 | hypothetical protein | 15 | 72 | 2.74 | 1.51E-10 | ||
| PA0125 | ParD antitoxin | 49.5 | 181 | 2.25 | 5.99E-22 | ||
| PA3531 | Bacterioferritin | 661.5 | 2766.5 | 2.46 | 1.20E-86 |